Case Management of Mild Cognitive Impairment and Anxiety-Depressive Disorder diagnosed after SARS-Cov2 Infection

Case presentation

Authors

  • Alexandra Oana Constantin “Carol Davila" University of Medicine and Pharmacy - Bucharest
  • Luiza Spiru “Carol Davila” University of Medicine and Pharmacy

Keywords:

SARS-COV2, mild cognitive impairment, anxiety, depression disorder

Abstract

Through this article, we want to highlight the importance of diagnosing earlier the MCI and anxiety disorder in order to be able to institute the necessary therapeutic measures and also to preserve the quality of life to a young patient.

Also the second very important aspect that we want to emphasize is that of the cognitive and behavioral disorders developed in the post Covid era and how to manage this pathology that the current medical world is facing in the new paradigms. Through these aspects we show once more the importance of extrinsic factors (such as professional stress, COVID infection, lifestyle and behaviors) in maintaining both physical and mental health and increasing the quality of life at the same time as increasing life expectancy.

Author Biographies

Alexandra Oana Constantin , “Carol Davila" University of Medicine and Pharmacy - Bucharest

PhD Student,“Carol Davila” University of Medicine and Pharmacy –Bucharest, Romania

MD, Department of Geriatrics and Gerontology II – Saint Luke’s Hospital for Chronic Diseases

Luiza Spiru, “Carol Davila” University of Medicine and Pharmacy

Prof. Dr., PhD, “Carol Davila” University of Medicine and Pharmacy – Bucharest

MD, Ana Aslan International Foundation – Center for Memory Diseases and Longevity Medicine - Bucharest

Published

2022-12-30

Most read articles by the same author(s)